SALISBURY, Md. — A Salisbury pharmaceutical company is voluntarily recalling birth control medication it produces due to concerns about the pills' efficacy.
A press release issued by Jubilant Cadista Pharmaceuticals Inc., the company that manufactures the Drospiernone and Ethinyl Estradiol tablets, said the pills may not serve as effective contraception due to “incomplete absorption of the active ingredients,” the release said. The company has yet to receive reports of adverse events related to the recall.
Drospirenone and Ethinyl Estradiol tablets are oral contraceptives utilizing estrogen and progestin. They are primarily taken to prevent pregnancy, but also may treat symptoms of premenstrual dysphoric disorder, or to treat moderate acne for women who are at least 14 years old.
The tablets are packaged in cartons containing three blister cards, with each car containing 28 tablets, 24 active tablets and four inert ones. The tablets subject to the recall include those with identifying lot number 183222, NDC number 59746-763-43 and an expiration date of 11/2020. They were distributed to national wholesalers, distributors and retailers.
Jubilant Cadista Pharmaceuticals Inc. is notifying customers via email and arranging for the return of all products in questions. Patients who may use this medication and have concerns should contact their healthcare providers. Consumers with additional questions can call 1-800-308-3985 fro, 9 a.m. to 6 p.m. Monday through Friday.
